Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 766 of 6351
-
New combo shot shows promise for kidney health in diabetes patients
Disease control CompletedThis study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight or obesity. CagriSema is a new investigational medicine. CagriSema cannot yet be prescribed by doctors. The study will compare CagriSema to …
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells take on tough leukemia in early trial
Disease control Recruiting nowThis study is a single-arm, open-label, dose-escalation clinical trial aimed at exploring the safety, tolerability, and pharmacokinetic characteristics of the CLL-1 CAR NK cells, as well as providing preliminary observations on its efficacy in subjects with relapsed/refractory ac…
Phase 1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New scan could help doctors spot hidden prostate cancer spread
Diagnosis OngoingThis is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate cancer.
Phase 3 • Sponsor: Curium US LLC • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Blood test may spot breast cancer return before symptoms appear
Disease control Recruiting nowThis trial is a multicenter, open-label, non-comparative, phase II, biomarker-driven adjuvant treatment study involving the periodic collection and analysis of blood samples from patients with HR-positive/HER2-negative early-stage BC at higher risk of relapse, who have undergone …
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New trial tests which radiation combo best fights liver cancer
Disease control Recruiting nowThe goal of this clinical trial is to compare the safety and efficacy of sequential Transarterial Chemoembolization (TACE) and Stereotactic body radiation therapy (SBRT) versus Y90-radioembolisation (SIRT), followed by systemic therapy in patients with large, locally advanced, un…
Phase 2/3 • Sponsor: Tuen Mun Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New Blood-Cleaning machine could help liver failure patients avoid transplant
Disease control Recruiting nowThe artificial liver support system (ALSS) in patients with acute on chronic liver failure - the use of combined molecular adsorption system with double plasma (DPMAS) and therapeutic plasma exchange (TPE), its effect on primary coagulation, inflammation and the function of vital…
Sponsor: Institute for Clinical and Experimental Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Virus therapy takes on cervical and endometrial cancer
Disease control Recruiting nowRecombinant oncolytic adenovirus injection (KD01)is an oncolytic vius product. Its main component is a conditionally replicativerecombinant human type 5 adenovirus, where part of the E3 region has been replaced with the gene encoding the tBid apoptoticprotein.AK104 is a humanized…
Phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug cocktail aims to halt aggressive breast cancer
Disease control By invitation onlyThis is a single-arm, multicenter, Phase II clinical study aiming to explore the efficacy and safety of Sacituzumab Govitecan combined with Bevacizumab as a second-line or later treatment for patients with metastatic triple-negative breast cancer (mTNBC). The study will be conduc…
Phase 2 • Sponsor: YING FAN • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a vaccine combo free people with HIV from daily pills?
Disease control PausedThe purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored conserved mosaic T-cell vaccines in a sequential regimen with the toll-like receptor…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New cocktail of drugs shows promise for stomach cancer patients
Disease control Recruiting nowPrimary Objectives * In phase 1b cohort, to determine MTD (maximum tolerated dose) of nal-IRI (ONIVYDE®) in combination with Ramucirumab (Cyramza®) and TAS-102 (LONSURF®) * In phase II cohort, to evaluate disease objective response rate (ORR) of Ramucirumab (Cyramza®), nal-IRI (…
Phase 1/2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy aims to shrink liver tumors in hard-to-treat colorectal cancer
Disease control Recruiting nowColorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide. Its early clinical manifestations are often subtle, leading to late-stage diagnosis in about 30% of cases with distant metastases. Liver metastases are widespread and associated with poor prognos…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo therapy aims to beat anal cancer recurrence
Disease control Recruiting nowSquamous cell carcinoma (SCC) of the anus is a rare malignancy. For localized anal squamous cell carcinoma , definitive chemoradiotherapy is the standard treatment. Patients who do not achieve complete response (CR)or experience recurrence require radical surgery with permanent c…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo shrinks lung tumors before surgery in early trial
Disease control OngoingPhase II, single-arm, open-label study that assess clinical feasibility and safety of neoadjuvant almonertinib followed by 3 cycles neoadjuvant adebrelimab plus chemotherapy in EGFR-mutant stage IIA-IIIB NSCLC followed by surgery, adjuvant treatment was upon investigators' decisi…
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Surgery for hidden lung cancer spread: a new hope for longer life?
Disease control Recruiting nowThis is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, a…
Sponsor: Fudan University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
A blood test for sleep apnea? MicroRNAs may hold the key
Diagnosis Recruiting nowAlthough obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification …
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Which nerve drug wins the battle against Post-Surgical knee pain?
Symptom relief Recruiting nowThe goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty. The main question\[s\] it aims to answer are: • Does mirogabalin have better pain reduction than pregabalin after unilateral primary…
Sponsor: Thammasat University Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can your own fat cells help restore skin color in vitiligo?
Disease control CompletedThis randomized, split-site, within-participant controlled clinical study evaluated the efficacy and safety of a single session of autologous nanofat injection as an adjunct to narrowband ultraviolet B (NB-UVB) phototherapy in 20 adult patients with stable vitiligo. In each parti…
Sponsor: Benha University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a Three-Pronged therapy reboot the brain after injury?
Disease control Recruiting nowThis study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Phase 4 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a new eye drop soothe dry, damaged eyes?
Disease control Recruiting nowThis is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.
Phase 3 • Sponsor: VivaVision Biotech, Inc • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a custom healing cap preserve gum and bone after tooth extraction?
Disease control Recruiting nowImmediate implant placement into a fresh extraction socket shortens overall treatment time and reduces the number of surgical procedures, but the fit between the implant and the socket walls, and the resulting soft-tissue contour, differ substantially between socket types. This s…
Sponsor: Plovdiv Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC